Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Curr Treat Options Oncol. 2016 Apr;17(4):17. doi: 10.1007/s11864-016-0393-5

Table.

Summary of studies of metabolic syndrome among adult survivors of childhood ALL

Author
Year
Time since
diagnosis
Age at
evaluation
Metabolic
syndrome
Increased waist
circumference/
adiposity
Elevated
Triglycerides
Low HDL-C Hypertension Elevated
blood
glucose
Risk
factors
identified
(N) years Years % % % % % %
Talvensaari [48] 1996 (28/50 with ALL) Range 8–21 10–31 16.0% 32% obese No mean difference survivors vs. controls Survivors lower mean values vs. controls No mean difference survivors vs. controls Higher mean values survivors vs. controls GHD
Kourti [66] 2005 (52) Median (since completion of therapy) 37 mo 3.1 years Median 15.2 5.8% 5.8% obese 23.1% 32.7%
Gurney [46] 2006 (75) Mean 25.0 Mean 30.0 16.6% 41.7% 20.6% 63.5% 21.1% 9.9% GHD and CRT
Trimis [67] 2007 (80) Median (since completion of therapy) 6.3 years Median 13.9 11.3% 25.0% obese 21.3% 12.5% 21.3% 15.0% (high HbA1c) CRT
van Waas* [49] 2010 (164/500 with ALL) Median 19.0 Median 28.0 13.0% 9.2% NR 9.80% 19.50% 1.0% CRT
Oudin [47] 2011 (184) Median 15.4 Median 21.2 9.2% 14.5% 13.0% 31.8% 25.3% 5.7% HCT with TBI
Nottage [42] 2014 (784) Median 26.1 Median 31.7 33.6% 39.9% 28.2% 44.6% 46.4% 31.4% CRT
Gunn [68] 2016 (N=226) Mean 12.6 Mean 18.0 32% obese 50.0% with dyslipidemia among CRT exposed = 19.0% 30.8% among CRT exposed CRT

HDL-C=High density lipoprotein cholesterol, GHD=Growth hormone deficiency, HCT=Hematopoietic cell transplantation, HbA1c=hemoglobin A1c, CRT=Cranial radiation Therapy, NR=Not reported,

*

Used a modified definition of metabolic syndrome with four components.